Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Nuvation Bio (NUVB-WT) Non Operating Investment Income (2023 - 2025)

Nuvation Bio (NUVB-WT) has disclosed Non Operating Investment Income for 3 consecutive years, with $3000.0 as the latest value for Q4 2025.

  • Quarterly Non Operating Investment Income fell 40.0% to $3000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5000.0 through Dec 2025, up 141.67% year-over-year, with the annual reading at $5000.0 for FY2025, 141.67% up from the prior year.
  • Non Operating Investment Income for Q4 2025 was $3000.0 at Nuvation Bio, up from -$1000.0 in the prior quarter.
  • The five-year high for Non Operating Investment Income was $44000.0 in Q4 2023, with the low at -$99000.0 in Q2 2023.
  • Average Non Operating Investment Income over 3 years is -$5000.0, with a median of $2000.0 recorded in 2024.
  • The sharpest move saw Non Operating Investment Income tumbled 191.67% in 2024, then surged 200.0% in 2025.
  • Over 3 years, Non Operating Investment Income stood at $44000.0 in 2023, then plummeted by 88.64% to $5000.0 in 2024, then plummeted by 40.0% to $3000.0 in 2025.
  • According to Business Quant data, Non Operating Investment Income over the past three periods came in at $3000.0, -$1000.0, and $3000.0 for Q4 2025, Q2 2025, and Q1 2025 respectively.